Hyperbaric oxygen before surgery for breast cancer
Part of Cancer, Skin clinical trials.
This trial tests if adding hyperbaric oxygen (breathing pure oxygen in a high-pressure chamber) to standard pre-surgery treatment can help women with triple-negative or HER2-positive breast cancer. The goal is to see if it makes treatment work better and is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 60 with a confirmed invasive breast cancer that is triple-negative or HER2-positive.
- Your cancer is early stage (stage II or III) and your doctor plans to give chemotherapy or targeted therapy before surgery.
- You have good overall health (ECOG 0-1) and normal heart, liver, kidney, and blood function.
- You have not had hyperbaric oxygen therapy in the past and have no condition that makes it unsafe (like certain lung or ear problems).
- You are not pregnant, not breastfeeding, and willing to avoid pregnancy during treatment and for 7 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests adding hyperbaric oxygen (breathing pure oxygen in a pressurized chamber) before standard chemotherapy for breast cancer. The goal is to see if it helps shrink the tumor more effectively before surgery.
This study tests adding hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) to standard neoadjuvant therapy (treatment before surgery) for people with hormone receptor positive breast cancer. The goal is to see if it helps shrink tumors more effectively while being safe.
This trial tests a combination of an oral chemotherapy pill (paclitaxel) with two targeted antibodies (pertuzumab and trastuzumab) given before surgery for HER2-positive breast cancer. The goal is to shrink the tumor and make surgery more effective.
This trial tests whether breathing pure oxygen in a pressurized chamber (hyperbaric oxygen) can prevent lung inflammation caused by breast cancer radiation. It may help reduce the risk of radiation pneumonitis in certain breast cancer survivors.
This trial tests whether hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) can help heal skin flaps that are not getting enough blood after breast cancer surgery. It may prevent tissue death and improve recovery.
This trial tests whether hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) can slow the growth of breast cancer that has spread to the lungs. You would receive this treatment alongside standard care if your cancer has grown despite prior chemotherapy.
Hear when a new Breast Cancers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.